Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

Overview of attention for article published in Stem Cell Research & Therapy, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 87 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 1,862 followers.

RT @NK_papers: Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical…

24 Mar 2022

Reply Repost Favourite

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial by Carmen Lúcia Kuniyoshi Rebelatto https://t.co/TIHRSWMio3

24 Mar 2022

Reply Repost Favourite

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial https://t.co/m6iqJH9pmG

23 Mar 2022

Reply Repost Favourite

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial by Carmen Lúcia Kuniyoshi Rebelatto https://t.co/YU9SVQ6L2O

23 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.